ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,412,032 | -16.5% | 184,830 | +12.9% | 0.06% | -28.4% |
| Q4 2022 | $2,888,673 | +7.5% | 163,757 | -7.1% | 0.08% | +1.2% |
| Q3 2022 | $2,686,000 | +26.4% | 176,350 | +23.1% | 0.08% | +17.6% |
| Q2 2022 | $2,125,000 | +24.5% | 143,281 | +89.0% | 0.07% | +28.3% |
| Q1 2022 | $1,707,000 | +81.4% | 75,817 | +48.7% | 0.05% | +76.7% |
| Q4 2021 | $941,000 | +43.0% | 50,999 | +3.6% | 0.03% | +11.1% |
| Q3 2021 | $658,000 | -24.1% | 49,207 | +5.1% | 0.03% | -27.0% |
| Q2 2021 | $867,000 | +144.9% | 46,828 | +98.8% | 0.04% | +131.2% |
| Q1 2021 | $354,000 | -45.0% | 23,550 | -47.2% | 0.02% | -23.8% |
| Q4 2020 | $644,000 | +4.7% | 44,628 | -40.9% | 0.02% | +5.0% |
| Q3 2020 | $615,000 | -3.3% | 75,551 | -19.6% | 0.02% | +5.3% |
| Q2 2020 | $636,000 | -73.2% | 94,008 | -72.1% | 0.02% | -71.2% |
| Q1 2020 | $2,373,000 | -47.9% | 337,060 | -27.4% | 0.07% | -21.4% |
| Q4 2019 | $4,556,000 | -20.4% | 464,221 | -11.0% | 0.08% | -16.8% |
| Q3 2019 | $5,726,000 | -26.8% | 521,511 | -22.4% | 0.10% | -19.2% |
| Q2 2019 | $7,819,000 | +59.3% | 672,343 | +30.7% | 0.12% | +73.6% |
| Q1 2019 | $4,907,000 | -31.7% | 514,309 | +2.0% | 0.07% | -27.3% |
| Q3 2018 | $7,183,000 | +26.2% | 504,092 | +6.3% | 0.10% | +20.7% |
| Q2 2018 | $5,692,000 | +585.8% | 474,326 | +731.9% | 0.08% | +583.3% |
| Q4 2017 | $830,000 | +62.7% | 57,019 | +59.0% | 0.01% | +71.4% |
| Q3 2017 | $510,000 | -78.5% | 35,871 | -80.8% | 0.01% | -75.0% |
| Q2 2016 | $2,370,000 | +12.0% | 186,620 | +16.5% | 0.03% | +16.7% |
| Q1 2016 | $2,116,000 | -90.7% | 160,157 | -89.2% | 0.02% | -90.3% |
| Q4 2015 | $22,758,000 | +198.7% | 1,479,705 | +140.8% | 0.25% | +233.8% |
| Q3 2015 | $7,620,000 | +2786.4% | 614,539 | +3365.7% | 0.07% | +722.2% |
| Q3 2013 | $264,000 | -9.0% | 17,732 | -20.8% | 0.01% | -25.0% |
| Q2 2013 | $290,000 | – | 22,394 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |